These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941 [TBL] [Abstract][Full Text] [Related]
6. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)]. Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218 [TBL] [Abstract][Full Text] [Related]
7. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260 [TBL] [Abstract][Full Text] [Related]
9. Assessing carbamazepine and oxcarbazepine-associated Stevens-Johnson syndrome/toxic epidermal necrolysis: Data mining the public version of the FDA adverse event reporting system. Xu C; Pan L; Zhang Y; Zhang J; Sun Q; Fang W Int J Clin Pract; 2021 Aug; 75(8):e14273. PubMed ID: 33908133 [TBL] [Abstract][Full Text] [Related]
11. Phenytoin induced Stevens-Johnson Syndrome-toxic Epidermal Necrolysis Overlap Exacerbated by Cephalexin in a 65-Year-old Neurosurgical Patient: A Rare Case Report. Rathinam KK; Sabarathinam S; Nuthalapati P; Mahalingam VT Curr Drug Res Rev; 2022; 14(1):80-83. PubMed ID: 34225642 [TBL] [Abstract][Full Text] [Related]
12. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study. Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729 [TBL] [Abstract][Full Text] [Related]
13. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica. East-Innis AD; Thompson DS West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894 [TBL] [Abstract][Full Text] [Related]
14. [Ophthalmic manifestations after Lyell and Stevens-Johnson syndromes]. Mouafik SB; Hocar O; Akhdari N; Amal S; Belghmaidi S; Ennassiri W; Hajji I; Moutaouakil A Ann Dermatol Venereol; 2015; 142(6-7):393-8. PubMed ID: 25896732 [TBL] [Abstract][Full Text] [Related]
15. Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. Antoon JW; Goldman JL; Lee B; Schwartz A Pediatr Dermatol; 2018 Mar; 35(2):182-187. PubMed ID: 29315761 [TBL] [Abstract][Full Text] [Related]
16. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164 [TBL] [Abstract][Full Text] [Related]
17. Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases. Kara A; Devrim İ; Çağlar İ; Bayram N; Kundak S; Apa H; Altan EV Turk J Pediatr; 2019; 61(4):538-543. PubMed ID: 31990471 [TBL] [Abstract][Full Text] [Related]
18. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin. Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867 [TBL] [Abstract][Full Text] [Related]
19. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475 [TBL] [Abstract][Full Text] [Related]